VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 510 filers reported holding VALEANT PHARMACEUTICALS INTL in Q4 2014. The put-call ratio across all filers is 1.37 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $938,000 | +3.4% | 65,480 | +25.0% | 0.00% | 0.0% |
| Q2 2017 | $907,000 | +59.7% | 52,400 | +1.7% | 0.00% | +100.0% |
| Q1 2017 | $568,000 | -21.1% | 51,500 | +3.8% | 0.00% | -33.3% |
| Q4 2016 | $720,000 | -43.6% | 49,600 | -4.6% | 0.00% | -40.0% |
| Q3 2016 | $1,277,000 | +18.2% | 52,000 | -3.0% | 0.01% | 0.0% |
| Q2 2016 | $1,080,000 | -28.7% | 53,600 | -6.9% | 0.01% | -28.6% |
| Q1 2016 | $1,515,000 | -76.1% | 57,600 | -7.7% | 0.01% | -74.1% |
| Q4 2015 | $6,343,000 | -72.1% | 62,400 | -51.0% | 0.03% | -73.5% |
| Q3 2015 | $22,729,000 | -6.3% | 127,420 | +16.7% | 0.10% | +2.0% |
| Q2 2015 | $24,263,000 | +35.1% | 109,220 | +20.8% | 0.10% | +38.9% |
| Q1 2015 | $17,955,000 | +131.5% | 90,400 | +66.8% | 0.07% | +118.2% |
| Q4 2014 | $7,757,000 | +15.2% | 54,200 | +5.7% | 0.03% | +17.9% |
| Q3 2014 | $6,731,000 | +2.8% | 51,300 | -1.2% | 0.03% | +3.7% |
| Q2 2014 | $6,546,000 | -4.7% | 51,900 | -0.4% | 0.03% | -15.6% |
| Q1 2014 | $6,868,000 | +13.6% | 52,100 | +1.2% | 0.03% | +28.0% |
| Q4 2013 | $6,046,000 | +13.9% | 51,500 | +1.2% | 0.02% | +4.2% |
| Q3 2013 | $5,310,000 | – | 50,900 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACCIPITER CAPITAL MANAGEMENT, LLC | 2,106,379 | $55,398,000 | 31.67% |
| Claren Road Asset Management, LLC | 80,000 | $2,820,000 | 24.27% |
| Okumus Fund Management Ltd. | 3,722,464 | $97,901,000 | 15.82% |
| Wingspan Investment Management, LP | 852,900 | $22,431,000 | 12.66% |
| FARLEY CAPITAL L.P. | 307,458 | $8,086,000 | 11.46% |
| Chou Associates Management | 976,843 | $25,725,000 | 8.35% |
| Wingspan Investment Management, LP | 550,700 | $14,483,000 | 8.17% |
| HAP Trading, LLC | 4,043,900 | $109,610,000 | 8.00% |
| LeVasseur Capital Partners LLC | 128,269 | $3,373,000 | 6.97% |
| Pershing Square Capital Management | 21,591,122 | $567,847,000 | 6.41% |